Kadmon Corporation To Present At Two Upcoming Investor Conferences

NEW YORK, NY--(Marketwired - March 19, 2015) - Kadmon Corporation, LLC, today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present an overview of Kadmon and its clinical and commercial programs at two upcoming investor conferences:

-- 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference on Friday, March 20th at 9:00 a.m. ET at the Millennium Broadway Hotel in New York City

-- JMP Securities Life Sciences Private Company Conference on Friday, March 27th at 9:30 a.m. ET at Le Parker Meridien in New York City

A live audio webcast of the BioCentury presentation will be accessible at https://www.webcaster4.com/Webcast/Page/818/7767. The webcast will be archived for 12 months.

About Kadmon Corporation
Kadmon Corporation, LLC, is a vertically integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs. We have a diversified product pipeline in autoimmune and fibrotic diseases, oncology, monogenic diseases and metabolic disease. For more information, visit www.kadmon.com.

This press release contains forward-looking statements. These forward-looking statements are based on management's expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. The information contained in this press release is believed to be current as of the date of original issue. Kadmon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.